BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DNA fingerprint
,
Trichostatin A
,
rs3825942
,
ZBTB7A
,
Influenza
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
motesanib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
NPR3
XIST
COL11A1
SERPINA3
AGR2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
regulation of nitrogen compound metabolic process
cytosol
organic cyclic compound binding
heterocyclic compound binding
organic cyclic compound metabolic process
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Acute myeloid leukemia xenografts with different imetelstat sensitivities
L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens
L1000 CMAP - Embryonic stem HUES3 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Characterization of In Vitro G-Quadruplex Formation of Imetelstat Telomerase Inhibitor.
Effect of topical motesanib in experimental corneal neovascularization model.
Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat.
Favorable overall survival with imetelstat in relapsed/refractory myelofibrosis patients compared wi…
Imetelstat in intermediate-2 or high-risk myelofibrosis refractory to JAK inhibitor: IMpactMF phase …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment o…
Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamou…
Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or M…
AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube …
Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ